Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric cancer is common globally and has a generally poor prognosis with a low 5-year survival rate. Targeted therapies and immunotherapies have improved the treatment landscape, providing more options for efficacious treatment. The use of these therapies requires predictive biomarker testing to id...

Descripción completa

Detalles Bibliográficos

Autores principales:	Christine Brezden-Masley, Pierre O. Fiset, Carol C. Cheung, Thomas Arnason, Justin Bateman, Martin Borduas, Gertruda Evaristo, Diana N. Ionescu, Howard J. Lim, Brandon S. Sheffield, Sara V. Soldera, Catherine J. Streutker
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2024-12-01
Colección:	Current Oncology
Materias:	gastric cancer immunohistochemistry IHC HER2 MMR CLDN18.2
Acceso en línea:	https://www.mdpi.com/1718-7729/31/12/572
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!